Selective immunoproteasome inhibition with Zetomipzomib for the treatment of lupus nephritis: Review of the open-label mission study results (LUPUS-KCR 2023) - May 20, 2023 - Pres time: May 20, 2023; 08:00 AM - 08:40 AM; Location: Grand Ballroom 105; "Sponsored by Kezar Life"
Clinical • Review • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|